Rhumbline Advisers Sells 4,688 Shares of Definitive Healthcare Corp. $DH

Rhumbline Advisers reduced its stake in Definitive Healthcare Corp. (NASDAQ:DH) by 5.8% during the 1st quarter, Holdings Channel reports. The fund owned 76,628 shares of the company’s stock after selling 4,688 shares during the period. Rhumbline Advisers’ holdings in Definitive Healthcare were worth $221,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Goldman Sachs Group Inc. lifted its holdings in Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock worth $25,191,000 after purchasing an additional 7,404,363 shares during the last quarter. Palisade Capital Management LP grew its holdings in Definitive Healthcare by 1.3% in the 1st quarter. Palisade Capital Management LP now owns 2,265,198 shares of the company’s stock valued at $6,546,000 after buying an additional 29,774 shares in the last quarter. Whetstone Capital Advisors LLC bought a new position in Definitive Healthcare during the 1st quarter worth $2,512,000. AQR Capital Management LLC lifted its holdings in shares of Definitive Healthcare by 56.7% during the first quarter. AQR Capital Management LLC now owns 590,149 shares of the company’s stock worth $1,706,000 after buying an additional 213,562 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Definitive Healthcare by 9.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 458,936 shares of the company’s stock valued at $1,326,000 after acquiring an additional 38,443 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on DH shares. Robert W. Baird set a $4.00 price target on shares of Definitive Healthcare in a research report on Friday, August 8th. Wall Street Zen raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, June 21st. Finally, Stifel Nicolaus boosted their price target on Definitive Healthcare from $5.00 to $6.00 and gave the company a “buy” rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $4.28.

Definitive Healthcare Stock Down 1.8%

Shares of DH opened at $3.85 on Friday. The firm has a 50 day simple moving average of $3.98 and a two-hundred day simple moving average of $3.47. The company has a market cap of $551.09 million, a P/E ratio of -1.45 and a beta of 1.65. Definitive Healthcare Corp. has a one year low of $2.15 and a one year high of $5.68. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.65 and a quick ratio of 1.65.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.